Barkhof F - Search Results

1

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.

Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F. Wattjes MP, et al. Among authors: barkhof f. Mult Scler. 2013 Dec;19(14):1826-40. doi: 10.1177/1352458513510224. Epub 2013 Nov 5. Mult Scler. 2013. PMID: 24192217 Review.

2

A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.

van Oosten BW, Lai M, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Hodgkinson S, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Mult Scler. 1996 Jul;1(6):339-42. doi: 10.1177/135245859600100611. Mult Scler. 1996. PMID: 9345413 Clinical Trial.

3

Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine.

Truyen L, Barkhof F, Frequin ST, Polman CH, Tobi H, Hommes OR, Valk J. Truyen L, et al. Among authors: barkhof f. Mult Scler. 1996 Feb;1(4):213-7. Mult Scler. 1996. PMID: 9345437

4

MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS).

Barkhof F. Barkhof F. Mult Scler. 1999 Aug;5(4):283-6. doi: 10.1177/135245859900500415. Mult Scler. 1999. PMID: 10467389 Review.

5

Magnetic resonance (MR) imaging as a marker for multiple sclerosis.

Castelijns JA, Barkhof F. Castelijns JA, et al. Among authors: barkhof f. Biomed Pharmacother. 1999 Sep;53(8):351-7. doi: 10.1016/s0753-3322(99)80106-1. Biomed Pharmacother. 1999. PMID: 10554669 Review.

6

Spinal cord magnetic resonance imaging in suspected multiple sclerosis.

Lycklama à Nijeholt GJ, Uitdehaag BM, Bergers E, Castelijns JA, Polman CH, Barkhof F. Lycklama à Nijeholt GJ, et al. Among authors: barkhof f. Eur Radiol. 2000;10(2):368-76. doi: 10.1007/s003300050058. Eur Radiol. 2000. PMID: 10663771

7

Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials.

Tan IL, Lycklama à Nijeholt GJ, Polman CH, Adèr HJ, Barkhof F. Tan IL, et al. Among authors: barkhof f. Mult Scler. 2000 Apr;6(2):99-104. doi: 10.1177/135245850000600208. Mult Scler. 2000. PMID: 10773855 Clinical Trial.

8

Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR.

Lazeron RH, Langdon DW, Filippi M, van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, Barkhof F. Lazeron RH, et al. Among authors: barkhof f. Mult Scler. 2000 Aug;6(4):280-5. doi: 10.1177/135245850000600410. Mult Scler. 2000. PMID: 10962549

9

Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

Killestein J, Rep MH, Barkhof F, Roos MT, Adèr HJ, van Lier RA, Polman CH. Killestein J, et al. Among authors: barkhof f. J Neuroimmunol. 2001 Aug 30;118(2):286-94. doi: 10.1016/s0165-5728(01)00346-0. J Neuroimmunol. 2001. PMID: 11498263 Clinical Trial.

10

TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.

Killestein J, Kalkers NF, Meilof JF, Barkhof F, van Lier RA, Polman CH. Killestein J, et al. Among authors: barkhof f. Neurology. 2001 Sep 25;57(6):1129-31. doi: 10.1212/wnl.57.6.1129. Neurology. 2001. PMID: 11571353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,525 results

Search Page

Filters